Suppr超能文献

维持性血液透析患者抗凝血酶III抗原血清水平、抗凝血酶活性及其AT-III-肝素复合物形成比率的研究

[Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].

作者信息

Yoshida K, Saka M, Kaneko Y, Kubota K, Hirao Y, Okajima E, Ishida M, Kihouin K, Motomiya Y

出版信息

Nihon Jinzo Gakkai Shi. 1989 Nov;31(11):1171-7.

PMID:2625740
Abstract

The plasma level of Antithrombin-III (AT-III) antigen, antithrombin activity and the ratio of AT-III-heparin complex formation have been studied in 20 patients with chronic glomerulonephritis on regular hemodialysis at two occasions with 2 year interval (in 1986 and 1988), and studied as to each variation in each plasma levels, and compared with the period of length of hemodialysis-history of individual cases. A significant decrease was found not only in plasma level of AT-III antigen (25.7 +/- 4.1 mg/dl to 23.4 +/- 3.9 mg/dl), but also in antithrombin activity (90.8 +/- 11.8% to 85.2 +/- 16.8%). Moreover and ratio of AT-III-heparin complex formation was significantly reduced during two years, too (50.7 +/- 3.0% to 53.0 +/- 1.5%). Similarly, a significant negative correlation could be found on the comparison between the duration of hemodialysis and each plasma levels of AT-III antigen (r = -0.27), antithrombin activity (r = -0.33), and as well as ratio of AT-III-heparin complex formation (r = -0.34). Therefore, it was interestingly suggested the possibility that prolonged hemodialysis treatment induced a functional loss of AT-III, especially in a capacity to form a AT-III-heparin complex due to partial loss of the affinity for heparin.

摘要

对20例接受定期血液透析的慢性肾小球肾炎患者,于1986年和1988年两个时间点(间隔2年)进行了抗凝血酶III(AT-III)抗原的血浆水平、抗凝血酶活性及AT-III-肝素复合物形成比例的研究,并对各血浆水平的变化情况进行了分析,同时与个体病例的血液透析史时长进行了比较。结果发现,不仅AT-III抗原的血浆水平显著降低(从25.7±4.1mg/dl降至23.4±3.9mg/dl),抗凝血酶活性也显著降低(从90.8±11.8%降至85.2±16.8%)。此外,两年间AT-III-肝素复合物形成比例也显著降低(从50.7±3.0%降至53.0±1.5%)。同样,在血液透析时长与AT-III抗原的各血浆水平(r = -0.27)、抗凝血酶活性(r = -0.33)以及AT-III-肝素复合物形成比例(r = -0.34)之间的比较中,均发现显著的负相关。因此,有趣的是,这提示了长期血液透析治疗可能导致AT-III功能丧失的可能性,尤其是由于对肝素亲和力部分丧失而形成AT-III-肝素复合物的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验